Centro De Ingenieria Genetica Y Biotecnologia

Eulogio Pimentel Vazquez

Osvaldo Reyes Acosta

Gerardo Enrique Guillen Nieto

Hilda Elisa Garay Perez

Jesús Arturo Junco Barranco

Eddy Emilio Bover Fuentes

Luis Alberto Aguero Barrocal

Niurka Oneysi Arteaga More

Maria Castro Santana

Lesvia Calzada Aguilera

Yovisleidys Lopez Saez

Roberto Basulto Baker

Franklin Fuentes Aguilar

Armando Tomas Hernadez Garcia

Carlos Borroto Nordelo

Juan Diego Mencho Ponce

Merardo Pujol Ferrero

Licette Leon Barreras

Marilin Domingo Puente

Oscar Compte Alberto

Marieta Marin Bruzos

Liuven Veloz Gonzalez

Jesus Mena Campos

Gerardo Enrique GUILLÉN Nieto

María Castro Santana

A pharmaceutical composition using natural gonadotropin&#x2014;releasing hormone (GnRH), and/or some of its mimetic peptides, indistinctly bound by its amino or carboxyl extremes to a carrier molecule; in one case by its carboxyl extreme and in the other case by the amino terminal extreme, thus eliciting a faster and more potent immunological response against the endogenous GnRH hormone. This finally leads to the ablation of the GnRH and consequently of the rest of the involved hormones in the stream GnRH/LH-FSH/Testosterone-(estrogens). An advantage of this formulation consists on facilitating the exposition to the immune system of a greater number of epitopes of the GnRH or its mimetics, minimizing thus the steric hindrance produced by the carriers. This invention has a direct application in the castration of pets and animals of economic interest, in the control of human fertility as well as in the treatment of hormone-sensitive tumors, such as that of the prostate, the breast, ovary, the endometry, testicles, hypophysis, salivary glands and other kinds of human tumors.

Pharmaceutical composition using gonadotropin-releasing hormone (GNRH) combined variants as immunogen

A pharmaceutical composition using natural gonadotropin-releasing hormone (GnRH), and/or some of its mimetic peptides, indistinctly bound by its amino or carboxyl extremes to a carrier molecule; in one case by its carboxyl extreme and in the other case by the amino terminal extreme, thus eliciting a faster and more potent immunological response against the endogenous GnRH hormone. This finally leads to the ablation of the GnRH and consequently of the rest of the involved hormones in the stream GnRH/LH-FSH/Testosterone-(estrogens). An advantage of this formulation consists on facilitating the exposition to the immune system of a greater number of epitopes of the GnRH or its mimetics, minimizing thus the steric hindrance produced by the carriers. This invention has a direct application in the castration of pets and animals of economic interest, in the control of human fertility as well as in the treatment of hormone-sensitive tumors, such as that of the prostate, the breast, ovary, the endometry, testicles, hypophysis, salivary glands and other kinds of human tumors.

This invention relates to pesticide and antiparasitic compositions for the control of pests, diseases and parasites attacking plants and animals. The compositions include, at least one chitinolytic agent or a chitinolytic activity-inducing agent, and sulfide or a sulfide-producing agent from microorganisms or chemical compounds, wherein the chitinolytic agent or the chitinolytic activity-inducing agent and sulfur or a sulfur-producing agent obtaining from microorganisms or chemical compounds are concurrently applied at a range significantly lower than any of the above-mentioned compounds, when they are individually to attain effective control.

Pesticidal and antiparasitic compositions

Growing community of inventors

Camaguey, Cuba

Eulogio Pimentel Vazquez